Summary

  • Sodium and phosphate are involved in the regulation of extracellular fluid and pH
  • Silica is an important connective tissue cross-linking agent and is required for the production and structural integrity of bone, cartilage, skin, hair, nails and soft tissues
  • The phosphate buffer system is one of the body’s important mechanisms for maintaining intracellular acid-base balance in which sodium monohydrogen phosphate and sodium dihydrogen phosphate act as efficient buffers in acid and alkaline conditions respectively
  • Silica acts as an important connective tissue cross-linking agent, contributing to the architecture and resilience of connective tissue by building bridges between elastin, collagen and mucopolysaccharides (such as chondroitin sulfate and other glycosaminoglycans), which aids in tissue stability and rigidity
  • In the early stages of bone development, silica is intimately involved in the incorporation of calcium and phosphate into bone apatite, helping to increase the rate of mineralisation of new bone
  • Silica acts as a nucleating agent or seed crystal around which bone mineralisation progresses, and thus is necessary for the initiation of bone growth (for example during foetal development and bone repair)
  • Silica is also involved in the growth of cartilage and teeth

Dosage & warnings

Adults and children over 12 years: 1 tablet 3 times daily with meals
Children under 12 years: As professionally prescribed

Contains sodium

Only take as directed.

Formulation

Downloads

This product is listed with the TGA - AustL 20305. The TGA publishes product info, including excipients under the "Other ingredients" subheading (not typically listed on the product label). Download the TGA public summary below.